refractory chronic myelomonocytic leukemia Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials
Online Trials
Age Group
Sitenames

Any (2)

Phase 1 (1)
Phase 2 (1)

INTERVENTIONAL (1)
Interventional (1)

M.D. Anderson Cancer Center (1)
Solu Therapeutics, Inc (1)

No (2)

Updated trials (1)

No (2)

Adult (18+) (2)

anderson (2)
cancer (2)
center (2)
d (1)
m (1)
md (1)

I am/have/had

I am/have/hadchronic myelomonocytic leukemia

I am/have/hadrefractory chronic myelomonocytic leukemia (cmml)

I am/have/hadcancer

I am/have/hadserum bilirubin

I am/have/hadhemolysis

I am/have/hadrefractory acute myeloid leukemia

I am/have/hadchronic myelomonocytic leukemia (cmml)

I am/have/hadrecurrent acute myeloid leukemia

I am/have/hadrefractory myelodysplastic syndrome

I am/have/hadleukemia recurrent

I am/have/hadrefractory aml

I am/have/hadrecurrent myelodysplastic syndrome

I am/have/hadleukemia

I am/have/hadrecurrent chronic myelomonocytic leukemia

I am/have/hadBRAF

I am/have/hadrefractory chronic myelomonocytic leukemia

I am/have/hadleukemia relapse

I am/have/hadHRAS

I am/have/hadacute myeloid leukemia

I am/have/hadmyeloid leukemia

added new label for I am/have/had

I am looking for

I am looking forchemotherapy drugs

I am looking forvenetoclax

I am looking forazacitidine

I am looking forkras

I am looking fortrametinib

added new label for I am looking for

Advanced Filters

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Includes pre-screening
Phase 1
Recruiting in 100s
Interventional Study
all
Hematology
Recruiting

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

This is a first-in-human, multicenter, open-label, phase 1 study to evaluate the safety, PK, PD and preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no further treatment options known to confer clinical benefit.

0 views
30 Apr, 2025

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Azacitidine Venetoclax and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome

This phase II trial investigates how well azacitidine, venetoclax, and trametinib work in treating patients with acute myeloid leukemia or higher-risk myelodysplastic syndrome that has come back (relapsed) or has not responded to treatment (refractory). Chemotherapy drugs, such as azacitidine, work in different ways to stop the growth of cancer …

azacitidine

chronic myelomonocytic leukemia

refractory chronic myelomonocytic leukemia (cmml)

cancer

venetoclax

0 views
16 Feb, 2024
1 location